Skip to main content
. Author manuscript; available in PMC: 2014 Feb 15.
Published in final edited form as: Biochem Pharmacol. 2012 Dec 17;85(4):10.1016/j.bcp.2012.12.005. doi: 10.1016/j.bcp.2012.12.005

Figure 2.

Figure 2

Compound 5 competitively inhibits TNYL-RAW binding to EphB4. Curves for the binding of the biotinylated TNYL-RAW peptide to immobilized EphB4 Fc in the presence of the indicated concentrations of compound 5. Kd, dissociation constant; Bmax, maximal binding. This experiment was repeated twice with similar results.